HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan.

Abstract
We studied the A55T, E164K, I225T, K153R and P198A variants in the myostatin (GDF8) gene, muscle strength and mass, and physical function during daily living in 41 nonagenarians [33 women, age range, 90, 97]. No participant carried a mutant allele of the aforementioned variants, except three participants (all women), who carried the R allele of the K153R polymorphism, with one of them (woman aged 96 years) being homozygous. Overall, in KR women muscle phenotype values (1RM leg press and estimated muscle mass) were low-to-normal compared to the whole group (approximately 25th-50th percentile), and their functional capacity (Barthel and Tinetti tests) was normal. In the woman bearing the RR genotype, values of muscle mass and functional capacity were below the 25th percentile. She is the first RR Caucasian whose phenotype has been characterised specifically. In summary, heterozygosity for the GDF8 K153R polymorphism does not seem to exert a negative influence on the muscle phenotypes of women who are at the end of the human lifespan, yet homozygosity might do so. More research on larger cohorts of nonagenarians is needed to corroborate the present findings.
AuthorsMarta González-Freire, Gabriel Rodríguez-Romo, Catalina Santiago, Natalia Bustamante-Ara, Thomas Yvert, Félix Gómez-Gallego, José A Serra Rexach, Jonatan R Ruiz, Alejandro Lucia
JournalAge (Dordrecht, Netherlands) (Age (Dordr)) Vol. 32 Issue 3 Pg. 405-9 (Sep 2010) ISSN: 1574-4647 [Electronic] Netherlands
PMID20640547 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Myostatin
Topics
  • Activities of Daily Living
  • Aged, 80 and over
  • Female
  • Humans
  • Myostatin (genetics)
  • Phenotype
  • Polymorphism, Genetic
  • Sarcopenia (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: